TransMedics Group is a publicly listed company tracked for investment-relevant business developments.
TransMedics' organ transplant technology addresses a growing market with new devices expanding TAM. Despite recent growth deceleration, 38% 3-year CAGR and 80% 5-year CAGR with operating leverage at 15x forward earnings and 3.5x EV/sales presents a rare profitable growth opportunity. The mission-driven model and profitability profile resemble Intuitive Surgical's early trajectory.